U.S. ex rel. v. Astrazeneca Biopharmaceuticals, Inc.

U.S. DISTRICT COURT
EASTERN DISTRICT OF NEW YORK
Civil Procedure

New York Law Journal

   | 0 Comments

FCA's First-to-File Rule Bars 'Off-Label' Claim But Fraud Claim is Alleged in Qui Tam Action

This premium content is reserved for New York Law Journal subscribers.

Continue reading by getting started with a subscription.

Already a subscriber? Log in now

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article #1202784152765

Thank you!

This article's comments will be reviewed.